ALS is a rare but cruel disease that slowly shuts down the body while leaving the mind intact. Doctors have only approved three drugs for it since the mid-1990s, and none of them cure or stop the disease—they merely slow it down a little. Part of the problem is money. Running trials for ALS is extre
The study tested a special floss that has 2% chlorhexidine, a strong cleaning chemical. Researchers wanted to know if it helps adults with gum inflammation (gingivitis). They randomly divided people into two groups. One group used the chlorhexidine‑floss every day for a month. The other
A research team set out to see if breathing exercises before operations could lower lung problems after surgery. The study involved patients scheduled for heart, chest and belly surgeries in the UK’s National Health Service. They ran a randomised controlled trial, meaning some patients received t
Doctors often face tough choices when treating aggressive brain tumors. A recent trial looked at how well a drug called regorafenib works in newly diagnosed and recurring glioblastoma cases. Instead of traditional methods, researchers used a flexible approach where patient data influenced treatment
In Canada, researchers often submit applications to ethics boards before starting a study. These forms normally ask for basic details about the trial, but they rarely prompt investigators to think about who will benefit from the research or how patients will be involved in decisions. The study lo
Doctors in the U. S. now have another tool to fight a tough cancer. The FDA gave the green light for early use of an experimental pill called daraxonrasib. It targets pancreatic ductal adenocarcinoma, a fast-spreading form of pancreatic cancer that has already resisted other treatments. Patients who
Research on semaglutide, a once-a-week shot, shows it can help people lose noticeable weight—up to one-sixth of their body weight in some cases. Trials called STEP 1, 3, and 4 focused on adults without diabetes and found weight drops between ten and seventeen percent. For those with type 2 diabetes
For decades, drug testing followed the same slow rhythm. Researchers ran trials in stages, then paused for months to analyze data before asking regulators for the next step. Patients waited years for treatments while paperwork piled up. Now, a new FDA approach cuts out the waiting by letting regulat
Quick action saves lives when someone has a heart attack. That’s why some emergency teams now give aspirin on the spot. But does this practice hold up under real-world conditions? A study called CELEBRATE looked at whether early aspirin use actually helps patients before they even get to the hospita
Research shows people with conditions like schizophrenia or bipolar disorder often struggle with obesity at higher rates than the general public. Medications they take and daily habits can lead to weight gain over time. Experts believe this issue needs more attention, especially since mental health
